Breast cancer epidemiology, prevention, and early detection

被引:38
作者
Brewster, A
Helzlsouer, K
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med Oncol, Baltimore, MD USA
关键词
D O I
10.1097/00001622-200111000-00002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer remains a worldwide public health concern despite the fact that mortality rates have been declining in some countries as a result of improvements in adjuvant therapy and screening for breast cancer. In the prevention arena, advances in our understanding of the effects of tamoxifen have led to the investigations of newer agents that may provide extended options for breast cancer prevention in high-risk women. For women who are carriers of a mutation in the breast cancer susceptibility genes BRCA1 or BRCA2, prophylactic oophorectomy and bilateral mastectomy have emerged as preventative surgical options that can significantly impact breast cancer risk. In addition, the identification of potentially modifiable risk factors for breast cancer such as dietary folate intake, alcohol consumption, physical activity, and certain anthropometric factors provides opportunities for intervening in breast cancer prevention both among women at average and high risk. The challenge remains in overcoming the limitations of mammography and clinical breast examination by developing and evaluating new technologies for breast cancer screening such as digital mammogram and breast magnetic resonance imaging. Curr Opin Oncol 2001, 13:420-425 (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:420 / 425
页数:6
相关论文
共 63 条
  • [41] Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers
    Rebbeck, TR
    Levin, AM
    Eisen, A
    Snyder, C
    Watson, P
    Cannon-Albright, L
    Isaacs, C
    Olopade, O
    Garber, JE
    Godwin, AK
    Daly, MB
    Narod, SA
    Neuhausen, SL
    Lynch, HT
    Weber, BL
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (17): : 1475 - 1479
  • [42] Rebbeck TR, 2000, J CLIN ONCOL, V18, p100S
  • [43] Dietary folate consumption and breast cancer risk
    Rohan, TE
    Jain, MG
    Howe, GR
    Miller, AB
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (03) : 266 - 269
  • [44] Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
    Ross, RK
    Paganini-Hill, A
    Wan, PC
    Pike, MC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (04): : 328 - 332
  • [45] Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
    Schairer, C
    Lubin, J
    Troisi, R
    Sturgeon, S
    Brinton, L
    Hoover, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (04): : 485 - 491
  • [46] Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women
    Sellers, TA
    Kushi, LH
    Cerhan, JR
    Vierkant, RA
    Gapstur, SM
    Vachon, CM
    Olson, JE
    Therneau, TM
    Folsom, AR
    [J]. EPIDEMIOLOGY, 2001, 12 (04) : 420 - 428
  • [47] Alcohol and breast cancer in women - A pooled analysis of cohort studies
    Smith-Warner, SA
    Spiegelman, D
    Yaun, SS
    van den Brandt, PA
    Folsom, AR
    Goldbohm, RA
    Graham, S
    Holmberg, L
    Howe, GR
    Marshall, JR
    Miller, AB
    Potter, JD
    Speizer, FE
    Willett, WC
    Wolk, A
    Hunter, DJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (07): : 535 - 540
  • [48] Intake of fruits and vegetables and risk of breast cancer - A pooled analysis of cohort studies
    Smith-Warner, SA
    Spiegelman, D
    Yaun, SS
    Adami, HO
    Beeson, WL
    van den Brandt, PA
    Folsom, AR
    Fraser, GE
    Freudenheim, JL
    Goldbohm, RA
    Graham, S
    Miller, AB
    Potter, JD
    Rohan, TE
    Speizer, FE
    Toniolo, P
    Willett, WC
    Wolk, A
    Zeleniuch-Jacquotte, A
    Hunter, DJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (06): : 769 - 776
  • [49] Smith-Warner SA, 2001, INT J CANCER, V92, P767, DOI 10.1002/1097-0215(20010601)92:5&lt
  • [50] 767::AID-IJC1247&gt